Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression

Podobne knjige/članki

• Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes
  od: Friedland, Julie C., et al.
  Izdano: (2013)
• The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
  od: He, Suqin, et al.
  Izdano: (2014)
• Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models
  od: Proia, David A., et al.
  Izdano: (2012)
• Androgen Receptor Splice Variants are Resistant to Inhibitors of Hsp90 and FKBP52, which alter Androgen Receptor Activity and Expression
  od: Shafi, Ayesha A., et al.
  Izdano: (2013)
• The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer
  od: Smith, Donald L., et al.
  Izdano: (2014)